191 related articles for article (PubMed ID: 34609410)
21. Anti-acetylcholine receptor antibody specificities in serum and in thymic cell culture supernatants from myasthenia gravis patients.
Heidenreich F; Vincent A; Willcox N; Newsom-Davis J
Neurology; 1988 Nov; 38(11):1784-8. PubMed ID: 3185915
[TBL] [Abstract][Full Text] [Related]
22. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
[TBL] [Abstract][Full Text] [Related]
23. Myasthenia Gravis with Toxic Goiter: Challenges with Management in a Low-Resource Setting in Africa; Review of Literature and Case Report.
Akerele JM; Erameh C; Okomayin AA; Dongo A; Omosofe F; Ikponmonsa G; Osemobor KO; Akerele NN; Ngwu S
Niger J Clin Pract; 2024 Jan; 27(1):148-152. PubMed ID: 38317049
[TBL] [Abstract][Full Text] [Related]
24. Anti-acetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis. Clinical correlations.
Kuks JB; Oosterhuis HJ; Limburg PC; The TH
J Autoimmun; 1991 Apr; 4(2):197-211. PubMed ID: 1883480
[TBL] [Abstract][Full Text] [Related]
25. Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor.
Vrolix K; Fraussen J; Losen M; Stevens J; Lazaridis K; Molenaar PC; Somers V; Bracho MA; Le Panse R; Stinissen P; Berrih-Aknin S; Maessen JG; Van Garsse L; Buurman WA; Tzartos SJ; De Baets MH; Martinez-Martinez P
J Autoimmun; 2014 Aug; 52():101-12. PubMed ID: 24439114
[TBL] [Abstract][Full Text] [Related]
26. Onset and Evolution of Clinically Apparent Myasthenia Gravis After Resection of Non-myasthenic Thymomas.
Mineo TC; Tamburrini A; Schillaci O; Ambrogi V
Semin Thorac Cardiovasc Surg; 2018; 30(2):222-227. PubMed ID: 29522809
[TBL] [Abstract][Full Text] [Related]
27. Correlation of anti-acetylcholine receptor antibody levels and long-term outcomes of juvenile myasthenia gravis in Taiwan: a case control study.
Chou CC; Su IC; Chou IJ; Lin JJ; Lan SY; Wang YS; Kong SS; Chen YJ; Hsieh MY; Hung PC; Wang HS; Chou ML; Lin KL;
BMC Neurol; 2019 Jul; 19(1):170. PubMed ID: 31319795
[TBL] [Abstract][Full Text] [Related]
28. Concurrent inflammatory myopathy and myasthenia gravis with or without thymic pathology: A case series and literature review.
Huang K; Shojania K; Chapman K; Amiri N; Dehghan N; Mezei M
Semin Arthritis Rheum; 2019 Feb; 48(4):745-751. PubMed ID: 29958689
[TBL] [Abstract][Full Text] [Related]
29. [Thymus CT scan and thymoma associated antibodies in myasthenia gravis with thymoma].
Li YF; Li YH; Cui LY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):517-9. PubMed ID: 16995304
[TBL] [Abstract][Full Text] [Related]
30. [Clinical characteristics and outcomes of myasthenia gravis patients with double positive antibodies against acetylcholine receptor and muscle-specific tyrosine kinase].
Lu YR; Yu L; Ma Q; Chen P; Qiu L; Ou CY; Lin ZZ; Liu WB
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(13):942-947. PubMed ID: 35385966
[No Abstract] [Full Text] [Related]
31. [The relationship between myasthenia gravis and the different pathological type of thymoma patients' operation and prognosis].
Zhang Y; Yu L; Jing Y; Ke J
Zhonghua Wai Ke Za Zhi; 2015 Aug; 53(8):612-6. PubMed ID: 26653963
[TBL] [Abstract][Full Text] [Related]
32. Thymus in myasthenia gravis: comparison of CT and pathologic findings and clinical outcome after thymectomy.
Nicolaou S; Müller NL; Li DK; Oger JJ
Radiology; 1996 Nov; 201(2):471-4. PubMed ID: 8888243
[TBL] [Abstract][Full Text] [Related]
33. Thymoma pathology and myasthenia gravis outcomes.
Menon D; Katzberg H; Barnett C; Pal P; Bezjak A; Keshavjee S; Bril V
Muscle Nerve; 2021 Jun; 63(6):868-873. PubMed ID: 33675078
[TBL] [Abstract][Full Text] [Related]
34. Myasthenia gravis: a study from India.
Singhal BS; Bhatia NS; Umesh T; Menon S
Neurol India; 2008; 56(3):352-5. PubMed ID: 18974563
[TBL] [Abstract][Full Text] [Related]
35. Myasthenia gravis with thymoma is not associated with an increased incidence of non-muscle autoimmune disorders.
Aarli JA; Gilhus NE; Matre R
Autoimmunity; 1992; 11(3):159-62. PubMed ID: 1571478
[TBL] [Abstract][Full Text] [Related]
36. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
[TBL] [Abstract][Full Text] [Related]
37. Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms.
Berrih-Aknin S; Le Panse R
J Autoimmun; 2014 Aug; 52():90-100. PubMed ID: 24389034
[TBL] [Abstract][Full Text] [Related]
38. [Thymoma Showing Elevating Anti-acetylcholine Receptor Antibody without Clinical Symptoms of Myasthenia Gravis;Report of a Case].
Ito T; Ishizumi T; Kataba H; Saijo T; Ikeda N
Kyobu Geka; 2018 Aug; 71(8):634-636. PubMed ID: 30185764
[TBL] [Abstract][Full Text] [Related]
39. Increased binding of anti-acetylcholine receptor antibodies to thymic antigen in patients with myasthenia gravis and other autoimmune diseases, as compared to those with myasthenia gravis alone.
Morel E; Raimond F; Bach JF
J Neuroimmunol; 1987 Mar; 14(2):221-6. PubMed ID: 3818943
[TBL] [Abstract][Full Text] [Related]
40. Response to treatment of myasthenia gravis according to clinical subtype.
Akaishi T; Suzuki Y; Imai T; Tsuda E; Minami N; Nagane Y; Uzawa A; Kawaguchi N; Masuda M; Konno S; Suzuki H; Murai H; Aoki M; Utsugisawa K
BMC Neurol; 2016 Nov; 16(1):225. PubMed ID: 27855632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
